Treatment of Endometrial Hyperplasias with Gonadotropin-Releasing Hormone Agonists: Pathological, Clinical, Morphometric, and DNA-Cytometric Data

By Agorastos T.   Bontis J.   Vakiani A.   Vavilis D.   Constantinidis T.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 102-114

Elsevier

Access to resources Recommend Favorite

Cell Cycle Arrest in Endometrial Carcinoma Cells Exposed to Gonadotropin-Releasing Hormone Analog

By Kim J.W.   Lee Y.S.   Kim B.K.   Park D.C.   Lee J.M.   Kim I.K.   Namkoong S.E.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 368-371

Elsevier

Access to resources Recommend Favorite

Differential Inhibitory Effects on Human Endometrial Carcinoma Cell Growth of Luteinizing Hormone-Releasing Hormone Analogues

By Borri P.   Coronnello M.   Noci I.   Pesciullesi A.   Peri A.   Caligiani R.   Maggi M.   Torricelli F.   Scarselli G.   Chieffi O.   Mazzei T.   Mini E.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 396-403

Elsevier

Access to resources Recommend Favorite

Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer

By Anderson John  

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 433-443

Future Medicine

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi   Vici Patrizia   Medico Pietro   Laudadio Lucio   Tomao Silverio   Giannarelli Diana   Pizzuti Laura   Sergi Domenico   Barba Maddalena   Maugeri-Saccà Marcello  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite